Here, we conducted a systematic study of pyroptosis-related genes (PRGs) in HCC to determine differences in the expression of these genes between tumour patients and nontumour patients, to assess the correlation between their expression and patient prognosis and to study the effects of these PRGs on the tumour-immune microenvironment. This evidence concerns the gene GART and hepatocellular carcinoma.